Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic … – GlobeNewswire (press release)
|
Sorrento Therapeutics Autologous Anti-CEA CAR–T Cell Therapy for Liver Metastases Demonstrates Therapeutic …
GlobeNewswire (press release) SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), cellular therapy focused subsidiary, TNK Therapeutics, Inc. (“TNK”), and Surefire Medical, Inc., announced today initial results from the Hepatic … Sorrento (SRNE) Says Anti-CEA CAR–T Cell Therapy for Liver Metastases Demonstrates Therapeutic Activity in Stage … Sorrento's liver artery-infused CAR–T cells showed positive effect in early-stage study |
